Pain relief study for ACL repair halted after only 3 patients
NCT ID NCT03643822
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if adding dexamethasone and/or dexmedetomidine to a standard nerve block could improve pain relief after ACL repair. Only 3 people enrolled before the study was stopped early. Because it was terminated with so few participants, it does not provide useful information about whether these additives help.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dexamethasone and dexmedetomidine (added to a nerve block)
- What this could lead to
- If it had succeeded, this could have pointed toward better pain control after ACL surgery, reducing the need for opioid painkillers.
- What could go wrong
- The trial was terminated early with only 3 participants, so no reliable conclusions can be drawn. The results are too limited to guide treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
3 people
The number who actually took part.
- Started
-
Feb 2020
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * English Speaking * ASA 1-3 patients * BMI \<40 Exclusion Criteria: * Refusal or inability to provide informed consent * Any contraindication to regional anesthesia including coagulopathy or bleeding diathesis, allergy to local anesthetics, infection, nerve injury or malignancy at the site of the block * History of alcohol/drug dependence * History of long term opioid intake or chronic pain disorder * History of preexisting neuropathy in the operative leg * History of significant psychiatric conditions that may affect patient assessment * Inability to understand the informed consent and demands of the study * Allergy to any of the components of the multimodal analgesic regimen * Revision of ACL repair * Diabetes * Significant bradycardia (baseline heart rate ≤ 40 beats per minute)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acl-injury are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Women's College Hospital
Toronto, Ontario, M5S 1B2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Light against pain: laser and infrared go head to head in ACL rehab
- 24 sensors map muscle oxygen after ACL surgery
- Which workout rebuilds a repaired knee best? a head-to-head trial of movement vs stability training
- Stem cell byproduct may boost ACL graft healing — trial puts it to the test
- Bone scaffold may help ACL grafts heal stronger
- Wearable shirt tracks surgeon fatigue during knee surgery